Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial | Lancet, The | 2020 | 189 |
YouTube as a source of information on COVID-19: a pandemic of misinformation? | BMJ Global Health | 2020 | 187 |
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research | Thrombosis and Haemostasis | 2020 | 147 |
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation | Transplantation | 2020 | 113 |
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer | Cancer Discovery | 2020 | 98 |
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study | JAMA Oncology | 2020 | 93 |
Humoral Responses and Serological Assays in SARS-CoV-2 Infections | Frontiers in Immunology | 2020 | 90 |
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper | Nature Reviews Clinical Oncology | 2020 | 82 |
A250 SYSTEMATIC REVIEW WITH META-ANALYSIS: ADVERSE PREGNANCY-RELATED OUTCOMES WITH INFLAMMATORY BOWEL DISEASE | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
MON-136 Reducing Unnecessary Inpatient Adrenocorticotropin Stimulation Tests | Journal of the Endocrine Society | 2020 | 78 |
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis | EClinicalMedicine | 2020 | 78 |
A147 ENDOSCOPIST FEEDBACK IS ASSOCIATED WITH IMPROVEMENTS IN COLONOSCOPY QUALITY INDICATORS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
A64 HOSPITALIZATION IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COMPARISON OF DEFINITIONS | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
A71 MESOCAVAL SHUNT EMBOLIZATION AS A TREATMENT FOR MEDICALLY REFRACTORY HEPATIC ENCEPHALOPATHY IN A PATIENT WITH NON-DECOMPENSATED CIRRHOSIS | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
A153 INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) & PROPHYLAXIS PRACTICES IN DECOMPENSATED CIRRHOSIS INPATIENTS | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
A272 THE CANADIAN DIRECT OBSERVATION OF PROCEDURAL SKILLS (CANDOPS) TOOL FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: A MULTI-CENTRE PROSPECTIVE STUDY | Journal of the Canadian Association of Gastroenterology | 2020 | 78 |
A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC) | Intensive Care Medicine | 2020 | 74 |
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial | Lancet Oncology, The | 2020 | 69 |
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration | Journal of Thrombosis and Haemostasis | 2020 | 69 |
Antiemetics: ASCO Guideline Update | Journal of Clinical Oncology | 2020 | 63 |
Frailty for Perioperative Clinicians: A Narrative Review | Anesthesia and Analgesia | 2020 | 50 |
AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs | Medical Physics | 2020 | 48 |
Management of meibomian gland dysfunction: a review | Survey of Ophthalmology | 2020 | 47 |
Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application | Stem Cells Translational Medicine | 2020 | 41 |
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma | Journal of Clinical Oncology | 2020 | 39 |